DRW-0739-02: Gen 2 Posterior Chairside Splint LRUL (lower right-upper left) - Product Usage: inte...

FDA Device Recall #Z-2638-2020 — Class II — May 14, 2020

Recall Summary

Recall Number Z-2638-2020
Classification Class II — Moderate risk
Date Initiated May 14, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Neocis Inc.
Location Miami, FL
Product Type Devices
Quantity 70 units

Product Description

DRW-0739-02: Gen 2 Posterior Chairside Splint LRUL (lower right-upper left) - Product Usage: intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery.

Reason for Recall

The LRUL and LLUR posterior chairside splints and LLUR anterior chairside splints may be mislabeled.

Distribution Pattern

US Nationwide distribution including in the states of AZ, CA, FL, NY, and NH

Lot / Code Information

Work Order (lot): 1616, 1621, and 1622

Other Recalls from Neocis Inc.

Recall # Classification Product Date
Z-2637-2020 Class II DRW-0739-01: Gen 2 Posterior Chairside Splint L... May 14, 2020
Z-2639-2020 Class II DRW-0742-01: Gen 2 Anterior Chairside Splint LL... May 14, 2020
Z-0511-2020 Class II Neocis Guidance System Fiducial Array - Product... Oct 4, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.